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Abstract Non-suicidal and suicidal self-injury are very
destructive, yet surprisingly common behaviours. Depres-
sed mood is a major risk factor for non-suicidal self-injury
(NSSI), suicidal ideation and suicide attempts. We con-
ducted a genetic risk prediction study to examine the
polygenic overlap of depressive symptoms with lifetime
NSSI, suicidal ideation, and suicide attempts in a sample of
6237 Australian adult twins and their family members
(3740 females, mean age = 42.4 years). Polygenic risk
scores for depressive symptoms significantly predicted
suicidal ideation, and some predictive ability was found for
suicide attempts; the polygenic risk scores explained a
significant amount of variance in suicidal ideation (lowest
p = 0.008, explained variance ranging from 0.10 to
0.16 %) and, less consistently, in suicide attempts (lowest
p = 0.04, explained variance ranging from 0.12 to
0.23 %). Polygenic risk scores did not significantly predict
NSSI. Results highlight that individuals genetically pre-
disposed to depression are also more likely to experience
suicidal ideation/behaviour, whereas we found no evidence
that this is also the case for NSSI.
Keywords Depression  Suicidal ideation  Suicide
attempts  Self-injury  Polygenic risk  Genetics
Intentional self-harm contravenes the fundamental drive of
self-preservation. However, both suicidal and non-suicidal
self-injurious (NSSI) behaviours (i.e., with and without the
direct intention to die, respectively) are surprisingly com-
mon in the population. Almost 1 in 10 adults have ever
thought about taking their own life, more than 1 in 20 have
engaged in NSSI, and more than 1 in 40 have attempted
suicide (Nock et al. 2008; Swannell et al. 2014). Moreover,
self-harm is the eighth leading cause of death in the US
(Rockett and Caine 2015). Recently, both a suicidal
behaviour disorder and NSSI disorder were included for the
first time in the DSM-5 as separate conditions for further
study (American Psychiatric Association 2013).
Several studies indicate that being depressed dramati-
cally increases the risk to engage in both non-suicidal
(Glenn and Klonsky 2013; Hankin and Abela 2011; Haw-
ton et al. 2013; Keenan et al. 2014; Nock et al. 2006;
Prinstein et al. 2010; Selby et al. 2012) and suicidal self-
injurious behaviours (Bernal et al. 2007; Brown et al. 2000;
Casey et al. 2006; Fergusson et al. 2005; Hawton et al.
2013; Sokero et al. 2005; Thompson and Light 2011;
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Tidemalm et al. 2008). A meta-analysis of psychiatric
disorders in patients presenting to hospital following self-
harm, showed that about 50 % of individuals also suffered
from depression (Hawton et al. 2013). In another study of
more than 20,000 suicide cases, depression and borderline
personality disorder were associated with the greatest
increase in suicide risk (Qin 2011). The fact that depression
is a major risk factor for self-injury may come as no sur-
prise given that depression often includes symptoms such
as hopelessness, negative affect, or recurrent thoughts of
death and suicide (American Psychiatric Association
2013). Depression and self-injurious behaviours may be
partly influenced by environmental factors, such as stress-
ful life events (e.g., abuse/assault, interpersonal problems
or employment difficulties; Haw and Hawton 2008;
Kendler et al. 1999). However, genetic factors also con-
tribute heavily to both self-injurious behaviours and
depression. Twin studies indicate that between 30 and
60 % of the variance in non-suicidal and suicidal self-in-
jurious behaviours and depression are attributable to genes
(Durrett 2006; Kendler et al. 2006; Maciejewski et al.
2014; Sullivan et al. 2000; Voracek and Loibl 2007; Wray
and Gottesman 2012). The identification of specific genetic
variants for depression and self-injurious behaviours has so
far achieved limited success (Galfalvy et al. 2011; Hek
et al. 2013; Major Depressive Disorder Working Group of
the Psychiatric 2013; Mullins et al. 2014; Schosser et al.
2011; Sokolowski et al. 2014; Willour et al. 2012),
although some SNPs have been identified for major
depression (Converge Consortium 2015) and depressive
symptoms (Okbay et al. 2016).
As both traits are substantially heritable, the association
between depression and self-injurious behaviours may be
partly due to overlapping genetic risk. Twin studies have
reported significant genetic correlations between suicidal
ideation and depression (Linker et al. 2012), and between
NSSI and internalizing disorders and suicide attempts and
internalizing disorders (Durrett 2006). Advances in data
availability (due to economically viable genome-wide
genotyping) and methodology now allow an alternative
means to directly test whether the genetic variance in
depression also predicts an increased risk for self-injurious
behaviours. Estimating the cumulative risk conferred by
multiple risk alleles is referred to as polygenic risk scoring
and has become increasingly popular for understanding
both the genetic architecture of traits and the covariance
between different traits (Dudbridge 2013).
Recently, a study has tested the association of polygenic
risk scores for major depressive disorder with suicidal
ideation and attempts in several target samples of mood
disorder patients (Mullins et al. 2014). The study showed
that polygenic risk scores for depression predicted suicidal
ideation in a target sample of 747 individuals with up to
1 % explained variance. The prediction results for suicide
attempts were inconsistent; the association did not reach
significance in the three individual target datasets, and was
significant only for two of the five subtests when com-
bining the three datasets (up to 0.3 % explained variance;
each subtest used different p value thresholds for inclusion
of genetic risk variants for depression to create the poly-
genic risk scores). Findings suggest that depression and
suicidal behaviours share some degree of genetic pleio-
tropy, but associations with suicide attempts were weak
and replication may thus be warranted to strengthen the
findings.
In this studywe aim to replicate and extend the findings of
Mullins et al. (2014) by performing polygenic risk scoring
analyses to test whether the aggregated effects of common
genetic variants underlying depression symptom count can
predict suicidal ideation, suicide attempts and NSSI in a
large population-based sample of 6237 individuals. Con-
trary to Mullins et al. (2014), whose polygenic risk scores
were derived from the Psychiatric Genomics Consortium
(PGC, N = 9240 mood disorder cases and 9519 controls;
Major Depressive Disorder Working Group of the Psychi-
atric 2013), the polygenic risk scores for the present study
were based on results from a genome-wide association study
on depressive symptom count (N = 34,549; Hek et al.
2013). We used this continuous measure, because depres-
sion lies on a continuum and even sub-threshold depression
is associated with increased suicidal risk (Ayuso-Mateos
et al. 2010; Fergusson et al. 2005; Lewinsohn et al. 2000)
and continuous measures—rather than clinical cut-offs—
provide increased statistical power in genetic studies on
psychopathology (van der Sluis et al. 2013). We used a
considerably larger target sample for suicidal ideation than
in the Mullins et al. study (2014; N = 6236 vs N = 747),
providing greater power to accurately estimate genetic
prediction. Importantly, this is the first study to estimate
whether a genetic predisposition to depressive symptoms is
associated with increased prevalence of NSSI.
Methods
Sample
The target sample consisted of twins and their family
members from the Australian Twin Registry, a population-
based twin registry. Between 1992 and 2009 these indi-
viduals participated in various semi-structured telephone
interviews focused primarily on psychiatric disorders;
details of the individual studies can be found elsewhere
(Heath et al. 1999, 2011; Knopik et al. 2004). In all studies,
the same items about NSSI, suicidal ideation, and suicide
attempt were included.
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Our final sample with both genotype and phenotype data
comprised 6237 participants (2497 males and 3740
females) from 3473 families, including 2115 monozygotic
and 2609 dizygotic twins and 1513 other family members.
The participant’s age at the time of the survey ranged from
19 to 89 years (M = 42.40, SD = 11.67).
Measures
Lifetime NSSI, suicidal ideation and suicide attempts were
assessed as part of the SSAGA (Semi-Structured Assess-
ment for the Genetics of Alcoholism), which assesses
alcoholism and related disorders. The SSAGA has been
shown to have good reliability and validity (Bucholz et al.
1994; Hesselbrock et al. 1999). The item used to determine
lifetime NSSI was: ‘‘Did you ever hurt yourself on purpose,
for example, by cutting or burning yourself?’’1; the item
used to determine suicidal ideation was: ‘‘Have you ever
thought about taking your own life?’’ and the item used to
determine suicide attempts was: ‘‘Have you ever tried to
take your own life?’’. All items were dichotomous (0 = no,
1 = yes). Complete data for NSSI, suicidal ideation, and
suicide attempts were available for 4223, 6236, and 6226
individuals, respectively. Note that one cohort did not
receive the question on NSSI, which accounts for the dif-
ferences in sample size.
Genotyping and quality control
DNA samples were collected in accordance with standard
protocols and genotyped on various Illumina single
nucleotide polymorphism (SNP) platforms (I317 K;
I370 K-Duo; I370 K-Quad; I610 K-Quad; I660 K). Stan-
dard platform specific quality control procedures (de-
scribed elsewhere; Medland et al. 2009) were applied
before imputation, including checks for ancestry outliers,
minor-allele frequency (MAF), Hardy–Weinberg Equilib-
rium (HWE), Mendelian errors and individual and SNP call
rate. SNPs were then imputed using MACH v1 reference
data from HapMap (Phases I and II, Release 22 Build 36).
Subsequently, we performed a second round of quality
control in which we deleted individuals with a call
rate\95 % and all SNPs with an imputation quality of
r2\ 0.30, MAF\ 0.01, HWE test p value\ 0.0001, or a
call rate\95 %. We also checked for strand-flips and
included only SNPs that were present in the summary
statistics of the full meta-analysis.
Generation of the polygenic scores and risk
prediction analysis
Polygenic risk scores for each individual in the target
sample were calculated in PLINK (Purcell et al. 2007)
using the p values and z-scores (converted into betas)
obtained from the summary statistics from the meta-anal-
ysis on depressive symptom count (Hek et al. 2013). The
polygenic scores for individuals in the target sample were
constructed by multiplying the number of copies of the
effect allele at each SNP by the regression beta weight, and
summing across SNPs. Scores were generated for nine
different p value cut-offs for inclusion of risk variants for
depressive symptoms (i.e P values of the association results
for the SNPs): 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5 and
1.0. Before generating the polygenic scores, we identified
‘independent’ signals of association in the GWA meta-
analysis results, using the linkage disequilibrium based
‘‘clumping’’ procedure as implemented in PLINK (Purcell
et al. 2007). We used an LD threshold of r2 = 0.25 within a
250-kb window and the clumping procedure was repeated
for all nine different risk prediction cut-offs (i.e. from
p\ 0.001 to p\ 1.0), using the corresponding p value
threshold (‘–clump-p1’). The number of SNPs that were
retained for the generation of the risk scores ranged from
N = 650 (for the significance threshold of p\ 0.001) to
N = 194,886 (for p = 1).
The risk prediction analysis was performed in SPSS
version 23 using generalized estimation equations (GEE)
with a logit link function. To account for relatedness of the
sample, an exchangeable conditional covariance matrix
was used (which allows for correlated residuals between
members of the same family) and tests were based on the
robust sandwich-corrected standard errors (Minica˘ et al.
2015). We included sex, age, birth cohort (before 1951,
1951–1965, after 1965), and the first ten principal com-
ponents of genetic variation (to correct for ancestry effects)
as covariates in the analyses. Variance explained by the
polygenic scores was calculated (in a logistic regression in
SPSS) as the Nagelkerke’s pseudo-R2 of the model
including polygenic scores and all covariates minus the
Nagelkerke’s pseudo-R2 of the model including only
covariates.
Results
Descriptive statistics
The overall prevalence for NSSI, suicidal ideation, and
suicide attempts were 3.2, 27.1, and 4.0 %, respectively.
Men and women did not differ on NSSI prevalence,
v2(1) = 0.01, p = 0.95. Men reported significantly more
1 If participants endorsed the suicide attempt items, then the NSSI
item started with ‘‘Other than when you tried to take your own life’’.
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suicidal thoughts, 29.4 % versus 25.6 %, v2(1) = 10.72,
p = 0.001, whereas women reported significantly more
suicide attempts, 4.5 versus 3.1 %, v2(1) = 7.47,
p = 0.006. Moreover, lifetime NSSI, suicidal ideation, and
suicide attempts were all associated with significantly
younger age, all ps\ 0.003. The phi coefficients between
NSSI and suicidal thoughts and attempts were u = 0.19
and u = 0.21 respectively, and u = 0.33 between suicidal
thoughts and suicide attempts (all ps\ 0.001).
Prediction
Results from the polygenic risk score analyses are shown in
Fig. 1. The polygenic risk scores for depressive symptoms
were significantly positively associated with suicidal
ideation in our target sample for all significance thresholds
from p\ 0.05 upwards, with the risk scores explaining
between 0.10 and 0.16 % of the variance in suicidal idea-
tion. This indicates that individuals with a genetic predis-
position to depression are also significantly more likely to
experience suicidal ideation.
The risk scores also significantly predicted suicide
attempts at the significance threshold of p\ 0.1, for which
the risk scores explained 0.23 % of the variance in suicide
attempts. However, prediction did not reach significance
for any of the other p value thresholds, even though the
variance explained for suicide attempts was between 0.12
and 0.23 % (for the thresholds from p\ 0.1 to p\ 1.0),
which is comparable to the variance explained in suicidal
ideation. Depressive symptoms risk scores did not signifi-
cantly predict variance in NSSI in our target sample under
any of the significance thresholds, with estimates of vari-
ance explained ranging between 0.03 and 0.20 %.
Discussion
Using a sample of 6,237 adults, we examined the extent to
which polygenic scores for depressive symptoms were
associated with an increased risk for suicidal ideation,
suicide attempts, and NSSI. Polygenic scores for depres-
sive symptoms consistently predicted suicidal ideation
(from significance thresholds of p\ 0.05 upwards for
inclusion of risk variants for depressive symptoms). When
including fewer SNPs from the depressive symptom count
GWAS (significance threshold of p\ 0.001 or p\ 0.01),
risk scores were not able to predict suicidal ideation or
attempt, emphasizing the polygenic architecture of the
traits. Some predictive ability was found for suicide
attempts, although only one of the significance thresholds
reached significance and thus results should be treated with
caution. The genetic risk scores explained a comparable
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Fig. 1 Results of polygenic risk score analysis. Variance explained
(Nagelkerke’s pseudo R2) in NSSI, suicidal ideation, and suicide
attempts by polygenic risk scores derived from depressive symptoms.
Polygenic scores were created using nine significance thresholds for
the inclusion of risk variants for depressive symptoms, ranging from
p = 0.001 to p = 1.0. Values on the outside end of each bar denote
the corresponding p value of the risk score prediction. p values at
p\ 0.05 are printed in bold
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amount of variance in suicidal ideation (between 0.10 and
0.16 %) and suicide attempts (between 0.12 and 0.23 %;
for significance thresholds of p\ 0.1 upwards). However,
our sample provided less power for suicide attempts, due to
a lower number of cases. Importantly, we estimated for the
first time whether a genetic predisposition to depressive
symptoms is associated with increased prevalence of NSSI,
and we found that polygenic risk scores did not predict
NSSI. Altogether, our results suggest that individuals who
are genetically vulnerable to depressive symptoms are at
higher risk for suicidal thoughts and potentially suicide
attempts, whereas no evidence was found for NSSI.
Our results for suicidal ideation and suicide attempt are
consistent with findings from another recent study in which
risk scores for major depressive disorder were found to be
associated with suicidal ideation and attempts in patients
with mood disorders, although the association with
attempts only reached significance when combining the
three target datasets (Mullins et al. 2014). Here we showed
that the association with suicidal ideation (and to a lesser
extent with suicide attempts) is also present in a popula-
tion-based sample (as opposed to a sample selected for
major depressive disorder) and using genetic risk scores for
a continuous measure of depressive symptoms rather than a
dichotomous measure of depressive disorder. Although
GWA studies have not been very successful in identifying
replicable genetic variants for major depressive disorder
(Major Depressive Disorder Working Group of the Psy-
chiatric 2013; although see Converge Consortium 2015) or
depressive symptoms (Hek et al. 2013), we and others
(Mullins et al. 2014) have shown that the aggregate effect
of many common genetic variants underlying depression
can explain a significant part of individuals’ liability to
suicidal self-injurious thoughts and behaviours. This evi-
dence provides additional support for current diagnostic
criteria for major depressive disorder, which include sui-
cidal ideation and behaviours.
We performed the first genetic risk prediction study for
NSSI. Although twin studies have indicated a genetic
overlap between NSSI and internalizing disorders (Durrett
2006), with the genetic risk prediction methodology, we
did not find evidence that a genetic predisposition to
depressive symptoms was associated with an increased risk
for NSSI. Estimates of explained variance (between 0.03
and 0.07 % for significance thresholds of p\ 0.1 upwards)
are somewhat lower than the explained variance for suicide
attempts and ideation. This may indicate a relatively lower
genetic covariation between depressive symptoms and
NSSI. Indeed, other studies have indicated that, on the
phenotypic level, the association of depression with NSSI
is somewhat lower than with suicidal behaviours (Claes
et al. 2010; Csorba et al. 2009; Dougherty et al. 2009).
Additionally, while our target sample was quite large
(N = 4223), the sample was smaller than for the other two
variables and the prevalence of NSSI was relatively low, so
the absence of a significant association may also be the
result of reduced power to detect small associations.
Some limitations need to be taken into account. First,
the phenotypes were based on single-item questions, which
may have introduced measurement error. For instance, with
regard to NSSI, we did not have data on the types of NSSI
and thus the category may contain also individuals which
have engaged in less severe NSSI (e.g., single instances of
hair pulling). Similarly, we did not differentiate between
brief and sustained suicidal thoughts. These rather hetero-
geneous categories may therefore limit the power to detect
polygenic effects. Indeed, the prevalence of suicidal idea-
tion was relatively high in our sample (27.1 %), higher
than in other studies (Nock et al. 2008). However, the
prevalences of NSSI and suicide attempts (3.2 and 4.0 %,
respectively) were comparable to other population studies
in adults (Nock et al. 2008; Swannell et al. 2014). Second,
although our risk scores can explain a significant amount of
the vulnerability to suicidal self-injurious behaviours, the
explained variance was very low, with the highest variance
explained being 0.16 % for suicidal ideation and 0.23 %
for suicide attempts. This is lower than in the study of
Mullins et al. (2014), whose major depressive disorder risk
scores explained up to 1 % of the variance in suicidal
ideation and 0.3 % in suicide attempts. However, poly-
genic risk scores for depression can so far only explain up
to 1 % variance in depression itself (Converge Consortium
2015; Demirkan et al. 2011; Major Depressive Disorder
Working Group of the Psychiatric 2013; Peyrot et al.
2014). The accuracy in risk prediction studies depends
largely on the size of the discovery sample from which
SNP effects are used to create polygenic scores. Very large
discovery samples are needed to accurately estimate single
SNP effects (Wray et al. 2013), because summing the
estimates of SNP effects also sums the error of those
estimates, creating statistical noise. While we used the
results from the largest GWAS meta-analysis of depression
related phenotypes to date, larger samples will provide
more accurate estimates of SNP effects leading to more
accurate risk prediction. The Psychiatric Genomics Con-
sortium is currently performing a second major depressive
disorder GWA meta-analysis with a larger sample size;
future studies using these results may be able to explain a
larger part of the variation. Moreover, a recent study sug-
gests that SNP effects for depression are more accurate
when using a more homogenous depression measure. This
study was the first to identify two loci of major depressive
disorder, which the authors attributed to the inclusion of
only homogenous cases with severe and recurrent depres-
sion episodes (Converge Consortium 2015). However,
even a small amount of variance explained in a phenotype
Behav Genet (2017) 47:3–10 7
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can have a critical influence on the development of a
particular condition, especially if the genetic predisposition
is a necessary precursor to the development of the
condition.
Here, the combined effects of thousands of major
depressive disorder SNPs only explained a small part of the
genetic variation in self-injurious behaviours. It is possible
that part of the genetic variation in self-injurious beha-
viours (and its genetic covariance with depression) is due
to genetic variance not taken into account in the current
risk-prediction methodology which only focusses on SNPs,
i.e. common genetic variants. Future studies may also
benefit from accounting for rare genetic variants and non-
additive genetic effects. On the other hand, Lubke et al.
(2012) showed that the vast majority of genetic variation
underlying major depressive disorder could be attributed to
common additive genetic effects.
Moreover, NSSI and suicidal ideation are likely to cap-
ture genetic liability to several traits in addition to depres-
sion. For instance, neuroticism (highly genetically
correlated with depression, rg = 0.75; Okbay et al. 2016),
anxiety, aggression, impulsivity, psychosis, and
schizophrenia may also play an important role in self-harm
behaviours (Alara¨isa¨nen et al. 2009; Chioqueta and Stiles
2005; Dumais et al. 2005; Haw et al. 2001; Kiekens et al.
2015; Koyanagi et al. 2015; Mc Closkey et al. 2012; Sareen
et al. 2005). Therefore, it would be interesting to investigate
the genetic association between self-harm and other psy-
chiatric disorders or traits in future risk prediction studies.
Further, environmental factors play a role in depression
and self-injurious behaviours (Haw and Hawton 2008;
Kendler et al. 1999). Thus, future studies could also
examine how the environment moderates the genetic risk
for depression to explain more variance in suicidal beha-
viours. A recent study found that the main effect of poly-
genic risk scores for depression as well as the interaction
between the polygenic risk scores with the environment
(childhood trauma) explained a comparable amount of
variance in major depressive disorder (both 0.5 %; Peyrot
et al. 2014).
In sum, the present study showed that a genetic pre-
disposition to depressive symptoms plays a role in the
pathogenesis of suicidal ideation, and possibly also in
suicide attempts. We, however, did not find evidence that
this is also the case for NSSI. Our results further emphasize
the polygenic nature of complex psychiatric traits; like
other mental disorders, self-injurious behaviours are likely
to be due to the aggregate effect of many genetic variants,
each of which on its own has a very small effect size.
Future studies based on results from larger discovery
samples, using larger target samples, and methodologies
taking into account non-additive genetic effects and rare
genetic variants as well as interactions between genes and
environment may be able to further disentangle the (ge-
netic) correlation between depression and self-injurious
behaviours.
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